Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Repaglinide + Bedtime Insulin vs Insulin Alone in T2DM
NCT01720303Phase 4Completed
- Sponsor
- Novo Nordisk
- Start
- Sep 2002
- Primary completion
- Apr 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of repaglinide in type 2 diabetes mellitus (T2DM), sponsored by Novo Nordisk. Started Sep 2002; status: completed.
02
Drugs
repaglinide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01720303.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01720303.